MarketPeel
Insider Trading Intelligence
JR

Jeffrey Scott Riley

GANX
DIRECTOR · GAIN THERAPEUTICS, INC. · CIK 0001487645
FILING MIX · LIFETIME100%/0%
BUYS
5
SELLS
0
TOTAL VALUE
$115.8K
COMPANIES
1
ACTIVE SINCE
Sep 2022
HOLDINGS NOW
15,000
AVG SELL PX
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Jeffrey Scott Riley, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-5.04%-1.91%-3.13%-3.13%
14d1+0.00%-10.88%-0.97%-9.91%-9.91%
30d1+0.00%-19.63%-2.83%-16.80%-16.80%
60d1+0.00%-36.07%+1.29%-37.36%-37.36%
90d1+0.00%-66.31%+4.63%-70.94%-70.94%
180d1+0.00%-57.03%+9.91%-66.94%-66.94%
1y1+0.00%-49.87%+7.58%-57.45%-57.45%
2y1+0.00%-51.46%+22.77%-74.23%-74.23%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GANX · 15,000 shares · as of Jun 24, 2025
07,50015,00022,50030,000202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 5 buys / 0 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GANX
GAIN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 24, 2025Jun 25, 2025View →
GANX
GAIN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 24, 2024Jun 26, 2024View →
GANX
GAIN THERAPEUTICS, INC.
PURCHASE
30,000$3.86$115.8K30,000Mar 28, 2024Apr 1, 2024View →
GANX
GAIN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,50010,500Jun 23, 2023Jun 26, 2023View →
GANX
GAIN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,50010,500Sep 20, 2022Sep 22, 2022View →
Other insiders · GANX
Loading peer insiders…
About this filer
CIK 0001487645
ROLE
Director
PRIMARY
GANX
COMPANIES
1
ACTIVE SINCE
Sep 2022
MARKETPEEL · /INSIDER/0001487645DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback